GO
Loading...

India

More

  • CHICAGO, Sept 17- Package delivery company FedEx Corp should enjoy a record holiday peak season thanks to the continued rise of online consumer sales in the United States, company officials said on Wednesday.

  • Sept 17- Lennar Corp, the second largest U.S. homebuilder, reported a better-than-expected 47 percent jump in quarterly profit as it sold more homes at higher prices, and its shares rose as much as 6 percent in premarket trading.

  • Steelmaker Nucor forecasts higher third-quarter profit Wednesday, 17 Sep 2014 | 9:14 AM ET

    Sept 17- Steelmaker Nucor Corp said it expects higher third-quarter profit, citing a rise in profitability from some steel products. The company forecast third-quarter profit of 70- 75 cents per share. It posted a profit of 46 cents per share for the third quarter last year.

  • Study shows downward trend in Sovaldi utilization Wednesday, 17 Sep 2014 | 8:38 AM ET

    Sept 17- Over the last several months there has been a' plateau and downward trend' in the use of Gilead Sciences Inc's controversial $1,000- a-pill hepatitis C treatment, Sovaldi, a CVS Health Corp analysis showed. The CVS Health Research Institute analyzed discontinuation rates for nearly 2,000 patients who filled prescriptions for Sovaldi since December.

  • Sept 17- General Mills Inc reported lower-than-expected quarterly profit and revenue as the maker of Cheerios cereal and Betty Crocker cake mixes lost further ground to cheaper store-branded foods amid rising demand for alternative breakfast options.

  • UPDATE 1-FedEx profit beats estimates as shipments rise Wednesday, 17 Sep 2014 | 8:20 AM ET

    Sept 17- FedEx Corp reported a better-than-expected 24 percent jump in quarterly profit as the world's No. 2 package delivery company benefited from higher shipment volume. The company's net income rose to $606 million, or $2. l0 per share, in the first quarter ended Aug. 31, from $489 million, or $1.53 per share, a year earlier.

  • Sept 17- Auxilium Pharmaceuticals Inc said it would not withdraw its offer to buy Canadian eye drug maker QLT Inc and adopted a poison pill, a day after receiving an unsolicited buyout offer from Endo International Plc.

  • Credit Suisse loans under US Fed scrutiny: Report Wednesday, 17 Sep 2014 | 8:09 AM ET

    The Federal Reserve has asked Credit Suisse to address problems relating to the bank's underwriting and sale of leveraged loans.

  • FedEx profit jumps 24 pct on higher shipment volume Wednesday, 17 Sep 2014 | 7:42 AM ET

    Sept 17- FedEx Corp reported a 24 percent rise in quarterly profit as the world's No. 2 package delivery company benefited from higher volumes in both its express and ground businesses. Net income rose to $606 million, or $2. l0 per share, in the first quarter ended Aug. 31 from $489 million, or $1.53 per share, a year earlier. Revenue increased 6 percent to $11.7 billion.

  • Sept 17- Laboratory equipment supplier VWR Corp said it expects its initial public offering of common stock to be priced between $22 and $25 per share, raising up to $638 million.

  • Sept 17- Auxilium Pharmaceuticals Inc adopted a poison pill with a 15 percent trigger, a day after an unsolicited $2.2 billion buyout offer from Endo International Plc.

  • General Mills profit falls 25 pct as sales decline Wednesday, 17 Sep 2014 | 7:09 AM ET

    Sept 17- General Mills Inc, the maker of Cheerios cereal and Betty Crocker cake mixes, reported a 25 percent fall in quarterly profit as sales fell for the fourth straight quarter and merchandising costs rose. The company's net income fell to $345.2 million, or 55 cents per share in the quarter ended Aug. 24, from $459.3 million, or 70 cents per share, a year earlier.

  • Sept 17- Lennar Corp, the second largest U.S. homebuilder, reported a higher-than-expected quarterly profit as it sold more homes at higher prices, and its shares rose about 6 percent in premarket trading.

  • UPDATE 1-Gilead's experimental drug fails mid-stage study Wednesday, 17 Sep 2014 | 6:47 AM ET

    Sept 17- Gilead Sciences Inc said its experimental drug did not significantly improve how long patients with a type of pancreatic cancer lived without the disease worsening. Separately, the biotechnology company also licensed Sovaldi to seven India- based drugmakers that will sell far cheaper versions of the drug in 91 developing nations.

  • Sept 17- Activist investor Nelson Peltz's Trian Fund Management LP, which holds a $1.6 billion stake in DuPont, called on the chemical conglomerate to separate its high-growth agriculture and other businesses from units that generate strong cash flows.

  • VWR Corp expects IPO to be priced at $22-$25/shr Wednesday, 17 Sep 2014 | 6:27 AM ET

    Sept 17- VWR Corp, a provider of laboratory supplies and services, said it expects its initial public offering of common stock to be priced between $22 and $25 per share. At the top end of the range, the company would be valued at about $3.19 billion. The company, which is offering 25.53 million shares, will raise up to $638.3 million from the float.

  • GILEAD'S EXPERIMENTAL CANCER DRUG FAILS IN MID-STAGE STUDY@. Sept 17- Gilead Sciences Inc said its experimental drug did not significantly improve the length of time that patients with a type of pancreatic cancer lived without the disease worsening.

  • UPDATE 1-Credit Suisse loans under U.S. Fed scrutiny -WSJ Wednesday, 17 Sep 2014 | 4:16 AM ET

    Federal Reserve has asked Credit Suisse to address problems relating to the bank's underwriting and sale of leveraged loans, the Wall Street Journal reported, citing a source familiar with the matter.

  • AHMEDABAD, India, Sept 17- A combination the "world's factory" and the "world's back office" will drive global economic growth, Chinese President Xi Jinping said ahead of a rare visit to India on Wednesday, playing down mistrust that has kept the Asian giants apart.

  • Trade, investment hopes as China's Xi visits India Wednesday, 17 Sep 2014 | 2:26 AM ET

    AHMEDABAD, India— Chinese President Xi Jinping landed in the Indian prime minister's home state of Gujarat on Wednesday for a three-day visit expected to focus on India's need to improve worn out infrastructure and reduce its trade deficit.